Discover an informative webinar that focuses on strategies and insights needed to comply with the Inflation Reduction Act (IRA) and capitalize on its new provisions for drug development, pricing and market access in the biopharmaceutical industry.
With the Inflation Reduction Act (IRA) now set as a cornerstone of modern healthcare legislation, adapting to its mandates is not just advisable but essential. This webinar focuses on equipping commercial and market access professionals with the knowledge and strategies needed to effectively adjust to the IRA’s provisions.
In this webinar, attendees will:
- LEARN the new compliance requirements and regulatory adjustments under the IRA
- EXPLORE the implications of the IRA on drug development, pricing and market access, and how to mitigate risk and capitalize on new opportunities
- DISCOVER strategic planning techniques to continue driving innovation while maintaining compliance with the new regulatory framework
Do not miss this opportunity to understand the enduring nature of these changes, the scope of data requirements and the strategic implications on drug development, pricing and market access, ensuring organizations not only comply but excel.
Register for this webinar today to understand how to navigate the complexities of the Inflation Reduction Act and its impact on biopharmaceuticals and the healthcare industry.
Speakers
Tiffany McCaslin, Managing Director, Value & Access Consulting, Syneos Health
With more than 20 years of experience in drug pricing, health policy development and government relations, Tiffany McCaslin has deep expertise on issues impacting health care and prescription drug coverage. She leverages her specific knowledge related to drug policy, correlating market forces, price influencers and prescription drug contracting to guide innovator market access strategy.
She brings a unique background to Syneos Health with industry and policy perspectives from her work as Executive Director for Market Access & Insights at EQRx, and through leadership positions at the Business Group on Health and PhRMA.
Tiffany’s broad experiences across public and private payer settings, within trade associations, and working intimately with large, self-insured plan-sponsors, brings a holistic understanding of the market access landscape and how to navigate it.
Message Presenter
Peter Zou, PhD, Director, Value & Access Consulting, Syneos Health
Peter Zou has nine years of experience in life sciences strategy consulting focusing on market access and pricing. He has over 10 years of undergraduate and PhD-level training in Biomedical Engineering and Neuroscience.
His work experience spans across broad therapeutic areas and product lifecycle stages focusing on payer landscape, value proposition, pricing, contracting, go-to-market strategy, coding / reimbursement strategy and execution for US and global markets.
Message PresenterWho Should Attend?
This webinar will appeal to biopharma executives involved in:
- Market access
- Pricing and reimbursement
- Health economics and outcomes research
- Regulatory affairs
- Pharmacy benefits
- Managed care and national accounts
- Commercial operations/strategy
- Pharmaceutical strategy
- Government affairs and health policy
What You Will Learn
In this webinar, attendees will:
- LEARN the new compliance requirements and regulatory adjustments under the Inflation Reduction Act
- EXPLORE the implications of the IRA on drug development, pricing and market access, and how to mitigate risk and capitalize on new opportunities
- DISCOVER strategic planning techniques to continue driving innovation while maintaining compliance with the new regulatory framework
Xtalks Partner
Syneos Health®
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. They translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together they share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. They support a diverse, equitable and inclusive culture.
To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account